ACHP-THP vs EC-THP as Neoadjuvant Therapy for HER2-positive EBC
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoadjuvant Chemotherapy
Interventions: DRUG: Doxorubicin liposome|DRUG: Cyclophosphamide|DRUG: Trastuzumab|DRUG: Docetaxel|DRUG: Epirubicin|DRUG: Pertuzumab|DRUG: Paclitaxel|DRUG: Paclitaxel-albumin
Sponsor: Sun Yat-sen University
Collaborators: First Affiliated Hospital, Sun Yat-Sen University|Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University